Citi analyst Geoff Meacham lowered the firm’s price target on Eli Lilly to $1,190 from $1,250 and keeps a Buy rating on the shares. Ahead of ...
Wells Fargo lowered the firm’s price target on Eli Lilly (LLY) to $970 from $1,000 and keeps an Overweight rating on the shares. The firm ...
CTRL Group Limited (the "Company") (NasdaqCM: MCTR), an integrated marketing and advertising services provider in Hong Kong specializing in mobile ...
IINN Inspira Technologies Oxy B.H.N. Ltd.